Trial Profile
Efficacy of vemurafenib in patients with BRAF V600 mutated advanced melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 25 Nov 2015 New trial record